Acute Ischemic Stroke Clinical Trials in Houston, Texas

5 studies are recruiting for acute ischemic stroke in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

   Extensive research is being conducted in search of neuroprotective agents for possible use in the acute phase of stroke and agents that can be used for neurorepair in later stages of stroke. Several trials have been conducted and are in progress using different pharmacological agents, but none of t…

   Stage

   Phase 3

   Ages

   18 to 80

   Site

   Houston Medical Neurological Institute, Houston, Texas

   Locations

   54 in total

   Run by

   Pharmazz, Inc.

   See if you can join NCT05691244 on ClinicalTrials.gov

2. REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

   Post-Market Registry

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Texas Health Science Center at Houston, Houston, Texas

   Locations

   3 in total

   Run by

   Medtronic Neurovascular Clinical Affairs

   See if you can join NCT07599904 on ClinicalTrials.gov

3. Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

   The purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of stroke onset. Participants will be randomized to receive one dose of either the investigational drug…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Memorial Hermann Hospital, Houston, Texas

   Locations

   25 in total

   Run by

   Basking Biosciences, Inc.

   See if you can join NCT06226805 on ClinicalTrials.gov

4. Optimizing Reperfusion to Improve Outcomes and Neurologic Function

   The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question the study aims to answer are: 1. JX10 improves functional outcomes as measured by the modified Rankin …

   Stage

   Phase 2

   Ages

   18 to 90

   Site

   Corxel Investigational Site, Houston, Texas

   Locations

   83 in total

   Run by

   Corxel Pharmaceuticals

   See if you can join NCT06990867 on ClinicalTrials.gov

5. Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

   The primary objective is to establish the efficacy of intra-arterial (IA) mechanical thrombectomy (MT) with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patients with acute ischemic stroke (AIS) from intracranial vessel occlusion (IVO) in the anterior circul…

   Stage

   Phase 3

   Ages

   18 to 79

   Site

   HCA Houston Kingwood, Houston, Texas

   Locations

   51 in total

   Run by

   Mercy Health Ohio

   See if you can join NCT05611242 on ClinicalTrials.gov